| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/14/2004 | CN1488354A Freeze-dried powder injection made from total flavone of may tree leaf |
| 04/14/2004 | CN1488351A Tincture for treating psoriasis |
| 04/14/2004 | CN1488349A Aspartic acid lomefloxacin powder and preparing method thereof |
| 04/14/2004 | CN1488348A Flurarizine dropping pill and preparing method thereof |
| 04/14/2004 | CN1488346A Melatonin two-layer release-controlled tablet and preparing process thereof |
| 04/14/2004 | CN1488345A Ranitidine hydrochloride capsule producing process |
| 04/14/2004 | CN1488342A Compressed-shaping formulation for hypnosis |
| 04/14/2004 | CN1488341A Ginseng-monkshood slow-release microporous for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488340A Ginseng-monkshood slow-release coating film controlled tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488339A Ginseng-monkshood slow-release coating skeleton piller for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488338A Ginseng-monkshood slow-release coating preparation film controlled piller for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488337A Ginseng-monkshood slow-release coating microporous film coated tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488336A Gineng-monkshood skeleton slow-releae insoluble skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488335A Ginseng-monkshood skeleton slow-release endo gastric detention tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488334A Ginseng-monkshood skeleton slow-release preparation wax skeleton tablet for treating qi athenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488333A Ginseng-monkshood skeleton slow-release hydrophilic gel skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488332A Pulse-release oral preparation and preparing method thereof |
| 04/14/2004 | CN1488331A Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
| 04/14/2004 | CN1488279A Zanthoxylum bungeanum esential oil and/or oily resin micro capsule and preparing process thereof |
| 04/14/2004 | CN1145660C Hair conditioner and use |
| 04/14/2004 | CN1145497C Enterogastric external nutrition composition and its pharmaceutic use thereof |
| 04/14/2004 | CN1145496C Novel formulation for peptide release |
| 04/14/2004 | CN1145493C Materials for preventing arteriosclerosis |
| 04/14/2004 | CN1145488C Sustained-release microgranules containing diltiazem as active principle |
| 04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
| 04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
| 04/14/2004 | CN1145484C Extended release tiagabine formulations with reduced side effects |
| 04/14/2004 | CN1145480C Contraceptive for male |
| 04/14/2004 | CN1145479C Pharmaceutical Preparation |
| 04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
| 04/14/2004 | CN1145477C Water-in-oil emulsion based on two specific emulsifiers and cosmetic apptications thereof |
| 04/13/2004 | US6721595 Percutaneous absorption promoters for electroporation |
| 04/13/2004 | US6720356 Magnesium di-potassium EDTA complex and method of administration |
| 04/13/2004 | US6720350 Reducing diminution in vessel lumen area with a therapeutic shunt having a cytoskeletal inhibitor to reduce stenosis or restenosis; taxols, cytochalasins |
| 04/13/2004 | US6720305 Ramoplanin (inn) is a known member of the cyclic peptide antibiotics more precisely known as glycolipodepsipeptides |
| 04/13/2004 | US6720024 Methods using dry powder deposition apparatuses |
| 04/13/2004 | US6720011 Injectable composition for cancer treatment |
| 04/13/2004 | US6720007 Useful as synthetic pigments, drug delivery vehicles, and protecting agents |
| 04/13/2004 | US6720005 Coated, platform-generating tablet |
| 04/13/2004 | US6720004 Mixed witha polymeric carrier to produce a certain dissolution profile; follows a zero-order release pattern producing flat plasma levels of valproate, once steady-state levels have been achieved; side effect reduction |
| 04/13/2004 | US6720003 Preparing a solution of paroxetine hydrochloride or sertaline hydrochloride and a water-soluble carrier in a co-solvent of a volatile solvent and water, and drying the solution |
| 04/13/2004 | US6720002 Solubility and storage stability while maintaining bioavailability of drug |
| 04/13/2004 | US6720001 Emulsion compositions for polyfunctional active ingredients |
| 04/13/2004 | US6720000 Process for producing wet ribavirin pellets |
| 04/13/2004 | US6719999 Lipid-regulating agent dissolved in one or more non-aqueous and/ or water-miscible solvents |
| 04/13/2004 | US6719998 Administering bisphosphonate or salt |
| 04/13/2004 | US6719997 Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers |
| 04/13/2004 | US6719996 Galenic composition for low bioavailability medicaments |
| 04/13/2004 | US6719995 Flexible polybutene strips for preventing gingivitis/whitening of teeth |
| 04/13/2004 | US6719994 Stability, dosage uniformity and tolerability of the formulation to the lungs |
| 04/13/2004 | US6719992 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| 04/13/2004 | US6719989 Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
| 04/13/2004 | US6719988 Mixture containing solvent, acid; complex |
| 04/13/2004 | US6719987 Sustained release of metal microbiocides |
| 04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
| 04/13/2004 | US6719963 Liquid oral compositions comprising a calcium compound and an acidulant |
| 04/13/2004 | US6719960 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 04/13/2004 | US6719933 Method for manufacturing seamless capsule |
| 04/13/2004 | US6719839 Stable dispersion such as of a porphyrin pigment, carmine, curcumin or a carotenoid in the form of bodies of given size, dispersed without use of a suface active substance in an an aqueous phase including a hydrocolloid; food coloring |
| 04/13/2004 | US6719751 Comprised of a polymer that is permeable to passage of biological fluids to form a semi-permeable outer tube wall, therapeutic agent disposed within |
| 04/13/2004 | US6719750 Non-linear (coil or z-shaped) body member body housing one or more substances and a delivery mechanism for the sustained delivery of the one or more substances from the non-linear shaped body member to the patient |
| 04/13/2004 | US6719740 Delivery system for topical skin care agents |
| 04/13/2004 | CA2374877C Pharmaceutical formulations and methods comprising intranasal morphine |
| 04/13/2004 | CA2348090C Oral pulsed dose drug delivery system |
| 04/13/2004 | CA2311122C Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2263557C Implant consisting of a carrier material containing medical substances and method to produce such an implant |
| 04/13/2004 | CA2219995C Implantable bioresorbable membrane and method for the preparation thereof |
| 04/13/2004 | CA2153780C Method of inhibiting viral reproduction |
| 04/13/2004 | CA2090953C High pullulan content product, and its preparation and uses |
| 04/08/2004 | WO2004029137A2 Cross-linked polymer matrices, and methods of making and using same |
| 04/08/2004 | WO2004029125A1 Water-swellable polymers |
| 04/08/2004 | WO2004029104A1 Phospholipid derivative |
| 04/08/2004 | WO2004029095A2 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 04/08/2004 | WO2004028677A2 Perfluorocarbon emulsions with non-fluorinated surfactants |
| 04/08/2004 | WO2004028673A1 Nanodevice for controlled charged particle flow and method for producing same |
| 04/08/2004 | WO2004028570A2 A method for treating severe tinnitus |
| 04/08/2004 | WO2004028569A1 Polymer compositions for administration to animals |
| 04/08/2004 | WO2004028567A1 Drug absorbability improving agents |
| 04/08/2004 | WO2004028560A1 Nucleic acid coated particles |
| 04/08/2004 | WO2004028557A1 Stabilized protein compositions |
| 04/08/2004 | WO2004028556A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 04/08/2004 | WO2004028549A1 A coixenolide capsules for treating prostate disease |
| 04/08/2004 | WO2004028536A1 Method for topical treatment of eye disease and composition and device for said treatment |
| 04/08/2004 | WO2004028534A1 Controlled releases system containing temozolomide |
| 04/08/2004 | WO2004028525A1 Choline ascorbate formulations |
| 04/08/2004 | WO2004028523A1 Particulate product comprising pantethine |
| 04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 04/08/2004 | WO2004028517A1 A method for treating severe tinnitus |
| 04/08/2004 | WO2004028515A1 Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
| 04/08/2004 | WO2004028514A1 Polymer composition and dosage forms comprising the same |
| 04/08/2004 | WO2004028513A1 Immediate release dosage form comprising shell having openings therein |
| 04/08/2004 | WO2004028512A1 Modified release dosage form with two cores |
| 04/08/2004 | WO2004028511A1 Solid dosage form comprising ketoprofen |
| 04/08/2004 | WO2004028510A1 Delayed release dosage forms |
| 04/08/2004 | WO2004028509A1 Sustained released delivery of amphetamine salts |
| 04/08/2004 | WO2004028508A1 Modified release dosage forms with two cores and an opening |
| 04/08/2004 | WO2004028507A1 Method to improve pharmaceutical tablets having a matrix of cellulose ether |
| 04/08/2004 | WO2004028506A1 Oral pharmaceutical compositions of fenofibrate having high bioavailability |
| 04/08/2004 | WO2004028505A1 Solid pharmaceutical formulations comprising telmisartan |